Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Yoshihito, Uchida"'
Autor:
Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira Shimada
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1220-1230 (2024)
ABSTRACT Aims/Introduction We conducted a 5 year post‐trial monitoring study of our previous randomized 24 week, open‐label, active‐controlled trial that showed beneficial effects of ipragliflozin on metabolic dysfunction‐associated steatotic
Externí odkaz:
https://doaj.org/article/c9c943d09a60435ca4995cce217880f0
Autor:
Shinpei Yamaba, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Akira Fuchigami, Hiroshi Uchiya, Nobuaki Nakayama, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0298770 (2024)
AimTo clarify the efficacy of atezolizumab (ATZ) plus bevacizumab (BEV) as the second-line therapy for patients with unresectable hepatocellular carcinoma (HCC).MethodsThe subjects were 82 patients with HCC receiving ATZ/BEV, including 33 patients wi
Externí odkaz:
https://doaj.org/article/8812e3f451694156a06fd5997bd55d92
Autor:
Yoshihito Uchida, Masamitsu Nakao, Shunsuke Yamada, Shohei Tsuji, Hayato Uemura, Jun-ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Background To evaluate the long-term efficacy of switching of the nucleos(t)ide analog used for treatment from entecavir (ETV) to tenofovir alafenamide fumarate (TAF) in patients with chronic HBV infection. Methods A total of 103 patients with serum
Externí odkaz:
https://doaj.org/article/6a3a4833242d41afb6d9d5ac9d3e3864
Autor:
Manabu Nakazawa, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Yoichi Saitoh, Yohei Fujii, Hiroshi Uchiya, Satsuki Ando, Nobuaki Nakayama, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Aim To establish a therapeutic strategy for cirrhosis patients with gastric variceal bleeding. Methods The outcomes of 137 patients with bleeding gastric varices were evaluated. Results The bleeding source was gastroesophageal varices (GOV) in 86 pat
Externí odkaz:
https://doaj.org/article/d32aa34a0db14e459e3d9c8543e6dc75
Autor:
Masahiro Kodana, Yuta Orihara, Mariko Tezuka, Rina Takahashi, Sakiko Noguchi, Nanako Matsuzaki, Tomohito Takada, Naomi Kobari, Kana Ogane, Rieko Kawamura, Toru Kawamura, Shinichi Takeuchi, Yuki Kamiyama, Rie Shiomi, Ryutaro Aoyagi, Masaya Saito, Takeru Kusano, Nobuaki Nakaya, Satoru Kaneko, Hideo Morita, Yoshihito Uchida, Hiroaki Yazawa, Ryu Sekiya, Kazuki Katayama, Shingo Mikami, Tomoya Sato, Norihito Tarumoto, Takehito Kobayashi, Hidetomo Nakamoto, Takuya Maeda
Publikováno v:
Journal of Infection and Chemotherapy. 29:586-591
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afa005c964ee7f2a647ff5356952b988
https://doi.org/10.1016/j.jiac.2023.02.011
https://doi.org/10.1016/j.jiac.2023.02.011
Autor:
Akira Fuchigami, Yukinori Imai, Yoshihito Uchida, Hiroshi Uchiya, Yohei Fujii, Manabu Nakazawa, Satsuki Ando, Kayoko Sugawara, Nobuaki Nakayama, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231427 (2020)
AIM:This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). METHODS:The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had
Externí odkaz:
https://doaj.org/article/d953b0efae3747dcb54da2e12f2cccbf
Autor:
Aya, Sato, Yukinori, Imai, Hiroshi, Uchiya, Yoshihito, Uchida, Manabu, Nakazawa, Kayoko, Sugawara, Nobuaki, Nakayama, Satoshi, Mochida
Publikováno v:
Internal Medicine. 61:2301-2305
We herein report two patients with hepatocellular carcinoma (HCC) who exhibited intraabdominal bleeding caused by tumor rupture soon after lenvatinib initiation. A hypervascular nodule was present in the lateral segment manifesting extrahepatic protr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce50adac0f76fbbdf49c80e123376d2
https://doi.org/10.2169/internalmedicine.8733-21
https://doi.org/10.2169/internalmedicine.8733-21
Autor:
Yoshihito Uchida, Yukinori Imai, Shohei Tsuji, Hayato Uemura, Jun‐ichi Kouyama, Kayoko Naiki, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Suguru Mizuno, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
Hepatology Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::171f552a249b661859996a9d0c6508c0
https://doi.org/10.1111/hepr.13926
https://doi.org/10.1111/hepr.13926
Autor:
Yoshihito Uchida, Yukinori Imai, Shohei Tsuji, Hayato Uemura, Jun-ichi Kouyama, Kayoko Naiki, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Suguru Mizuno, Tomoaki Tomiya, Satoshi Mochida
Aim: To determine the significance of the portal venous blood flow and portosystemic shunts in patients with decompensated cirrhosis due to HCV infection following SVR achievement. Methods: Portal hypertension-related events and liver function were e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d07940e18c9f80a1d0a571ee8b3d877
https://doi.org/10.21203/rs.3.rs-2423520/v1
https://doi.org/10.21203/rs.3.rs-2423520/v1
Autor:
Yoshihito Uchida, Kayoko Naiki, Jun-Ichi Kouyama, Kayoko Sugawara, Masamitsu Nakao, Daisuke Motoya, Mie Inao, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205600 (2018)
AIMS:Liver injury can occur during antiviral therapies with direct-acting antivirals (DAAs), potentially necessitating discontinuation of the therapies, with consequent worsening of the sustained viral response (SVR) rates, in patients with hepatitis
Externí odkaz:
https://doaj.org/article/67a6ad365b4a41b4906a1879175a2116